Home LiteratureArticle Details
PMID: 11782979 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

PARK6-linked parkinsonism occurs in several European families.

Annals of neurology ·Vol. 51 ·No. 1 ·2002-01-00 ·Pages 14-8

Valente EM, Brancati F, Ferraris A, Graham EA, Davis MB, Breteler MM, Gasser T, Bonifati V, Bentivoglio AR, De Michele G, Dürr A, Cortelli P, Wassilowsky D, Harhangi BS, Rawal N, Caputo V, Filla A, Meco G, Oostra BA, Brice A, Albanese A, Dallapiccola B, Wood NW, European Consortium on Genetic Susceptibility in Parkinson's Disease

Abstract

The Parkin gene on 6q25.2-27 is responsible for about 50% of autosomal recessive juvenile parkinsonism and less than 20% of sporadic early-onset cases. We recently mapped a novel locus for early-onset parkinsonism (PARK6) on chromosome 1p35-p36 in a large family from Sicily. We now confirm linkage to PARK6 in eight additional families with Parkin-negative autosomal recessive juvenile parkinsonism from four different European countries. The maximum cumulative pairwise LOD score was 5.39 for marker D1S478. Multipoint linkage analysis gave the highest cumulative LOD score of 6.29 for marker D1S478. Haplotype construction and determination of the smallest region of homozygosity in one consanguineous family has reduced the candidate interval to a 9cM region between markers D1S483 and D1S2674. No common haplotype could be detected, excluding a common founder effect. These families share some clinical features with the phenotype reported for European Parkin-positive cases, with a wide range of ages at onset (up to 68 yrs) and slow progression. However, features typical of autosomal recessive juvenile parkinsonism, including dystonia at onset and sleep benefit, were not observed in PARK6-linked families, thus making the clinical presentation of late-onset cases indistinguishable from idiopathic Parkinson's disease. PARK6 appears to be an important locus for early-onset parkinsonism in European Parkin-negative patients.

MeSH Terms
Adult Age of Onset Antiparkinson Agents/therapeutic use Chromosomes, Human, Pair 1 Europe Family Health Female Founder Effect Genetic Linkage Haplotypes Humans Levodopa/therapeutic use Male Middle Aged Parkinson Disease/drug therapy,genetics Pedigree Phenotype
Chemicals
Antiparkinson Agents Levodopa
Authors & Affiliations
24 authors, click to expand affiliations / ORCID
Valente Enza Maria
Institute for Medical Genetics C.S.S. Mendel, Rome, Italy.
Brancati Francesco
Ferraris Alessandro
Graham Elizabeth A
Davis Mary B
Breteler Monique M B
Gasser Thomas
Bonifati Vincenzo
Bentivoglio Anna Rita
De Michele Giuseppe
Dürr Alexandra
Cortelli Pietro
Wassilowsky Dietmar
Harhangi Biswadjiet S
Rawal Nina
Caputo Viviana
Filla Alessandro
Meco Giuseppe
Oostra Ben A
Brice Alexis
Albanese Alberto
Dallapiccola Bruno
Wood Nicholas W
European Consortium on Genetic Susceptibility in Parkinson's Disease
Article Info
Journal
Annals of neurology
Abbr.
Ann Neurol
ISSN
0364-5134
Published
2002-01-00
Pages
14-8
Language
English
Region
United States
NLM ID
7707449
Subset
IM
Grants
Telethon · C.38 · Italy
Telethon · E.1165 · Italy
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]